Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Most outdoor brand logos are bland as a soggy sandwich left out in the rain. But not Patagonia's. Their logo is like a breath of fresh mountain air in a world of corporate stuffiness. I remember the ...

If there's one thing that can instantly grab our attention and make a lasting impression, it's a well-crafted logo. Whether the sleek curves of Nike's iconic swoosh or the bold simplicity of Adidas' ...

After hours: February 14 at 6:21:04 PM EST Loading Chart for GDTC ...